Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
Open Access
- 19 October 2020
- journal article
- research article
- Published by Hindawi Limited in International Journal of Nephrology
- Vol. 2020, 1-7
Abstract
Background. Lupus nephritis (LN) can be complicated with requirement for kidney replacement therapy and death. Efficacy of induction therapies using mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVCYC) has been reported from studies, but there is limited data in Africans comparing both treatments in patients with proliferative LN. Methods. This was a retrospective study of patients with biopsy-proven proliferative LN diagnosed and treated with either MMF or IVCYC in a single centre in Cape Town, South Africa, over a 5-year period. The primary outcome was attaining complete remission after completion of induction therapy. Results. Of the 84 patients included, mean age was 29.6 ± 10.4 years and there was a female preponderance (88.1%). At baseline, there were significant differences in estimated glomerular filtration rate (eGFR) and presence of glomerular crescents between both groups ( ). After completion of induction therapy, there was no significant difference in remission status (76.0% versus 87.5%; ) or relapse status (8.1% versus 10.3%; ) for the IVCYC and MMF groups, respectively. Mortality rate for the IVCYC group was 5.5 per 10,000 person-days of follow-up compared to 1.5 per 10,000 person-days of follow-up for the MMF group ( ), and there was no significant difference in infection-related adverse events between both groups. Estimated GFR at baseline was the only predictor of death (OR: 1.0 [0.9–1.0]; ). Conclusion. This study shows similar outcomes following induction treatment with MMF or IVCYC in patients with biopsy-proven proliferative LN in South Africa. However, a prospective and randomized study is needed to adequately assess these outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Outcome of patients with membranous lupus nephritis in Cape Town South AfricaNephrology Dialysis Transplantation, 2012
- Clinicopathological insights into lupus nephritis in South Africans: a study of 251 patientsLupus, 2012
- Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective studyModern Rheumatology, 2012
- Predictors of poor renal outcome in patients with biopsy‐proven lupus nephritisNephrology, 2010
- Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysisLupus, 2009
- Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patientsLupus, 2009
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- Causes and predictors of death in South Africans with systemic lupus erythematosusRheumatology, 2007
- Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosisLupus, 2002
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999